Insights from the molecular docking analysis of EGFR antagonists

Overexpression of the epidermal growth factor receptor (EGFR) has been shown to be a critical factor in tumor development and cancer progression. Although established EGFR inhibitors have been effective in the treatment of cancer, they are associated with several side effects. As a result, there is...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamal, Mohammad Azhar, M Baeissa, Hanadi, J. Hakeem, Israa, S Alazragi, Reem, S.Hazzazi, Mohannad, Bakhsh, Tahani, Aslam, Akhmed, Refaat, Bassem, B. Khidir, Elshiekh, Juma Alkhenaizi, Kadhem, Alam, Qamre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557452/
https://www.ncbi.nlm.nih.gov/pubmed/37808374
http://dx.doi.org/10.6026/97320630019260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557452/
https://www.ncbi.nlm.nih.gov/pubmed/37808374
http://dx.doi.org/10.6026/97320630019260

Ejemplares similares